Advert - Colonis

For sending a letter that promoted Melatonin 1mg/ml oral solution for off-label use and prejudiced patient safety, Colonis was ruled in breach of the following clauses of the Code:

Clause 2 -         Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.2 -     Promoting a medicine for an unlicensed indication

Clause 9.1 -     Failing to maintain high standards